125 related articles for article (PubMed ID: 36790356)
21. Computational analyses of type 2 diabetes-associated loci identified by genome-wide association studies.
Cheng M; Liu X; Yang M; Han L; Xu A; Huang Q
J Diabetes; 2017 Apr; 9(4):362-377. PubMed ID: 27121852
[TBL] [Abstract][Full Text] [Related]
22. Identification of key regulators in parathyroid adenoma using an integrative gene network analysis.
Imam N; Alam A; Siddiqui MF; Ahmed MM; Malik MZ; Ikbal Khan MJ; Ishrat R
Bioinformation; 2020; 16(11):910-922. PubMed ID: 34803267
[TBL] [Abstract][Full Text] [Related]
23. Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension.
Jesmin J; Rashid MS; Jamil H; Hontecillas R; Bassaganya-Riera J
BMC Med Genomics; 2010 Oct; 3():45. PubMed ID: 20942928
[TBL] [Abstract][Full Text] [Related]
24. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
25. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S; Krohn K; Lamesch P; Müller A; Paschke R
Eur J Endocrinol; 2000 Jul; 143(1):47-54. PubMed ID: 10870030
[TBL] [Abstract][Full Text] [Related]
26. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic insights into sporadic primary hyperparathyroidism.
Brewer K; Costa-Guda J; Arnold A
Endocr Relat Cancer; 2019 Feb; 26(2):R53-R72. PubMed ID: 30475215
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach.
Gupta MK; Vadde R
Comput Biol Chem; 2019 Apr; 79():24-35. PubMed ID: 30708140
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
30. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
[TBL] [Abstract][Full Text] [Related]
31. An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
Glasgow C; Lau EYC; Aloj L; Harper I; Cheow H; Das T; Berman L; Powlson AS; Bashari WA; Challis BG; Marker A; Moyle P; Mohamed IA; Schoenmakers N; Broomfield J; Oddy S; Moran C; Gurnell M; Jani P; Masterson L; Fish B; Casey RT
J Clin Endocrinol Metab; 2022 May; 107(6):1706-1713. PubMed ID: 35150267
[TBL] [Abstract][Full Text] [Related]
32. Identification of key nodes of type 2 diabetes mellitus protein interactome and study of their interactions with phloridzin.
Randhawa V; Sharma P; Bhushan S; Bagler G
OMICS; 2013 Jun; 17(6):302-17. PubMed ID: 23692363
[TBL] [Abstract][Full Text] [Related]
33. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
[TBL] [Abstract][Full Text] [Related]
34. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
35. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
Wu M; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathology of parathyroid tumors.
Carling T
Trends Endocrinol Metab; 2001 Mar; 12(2):53-8. PubMed ID: 11167122
[TBL] [Abstract][Full Text] [Related]
38. Sporadic parathyroid adenoma: an updated review of molecular genetics.
Chorti A; Cheva A; Chatzikyriakidou A; Achilla C; Boulogeorgou K; Despoina K; Milias S; Zarampoukas T; Papavramidis T
Front Endocrinol (Lausanne); 2023; 14():1180211. PubMed ID: 37223014
[TBL] [Abstract][Full Text] [Related]
39. Shared Genetic Contribution of Type 2 Diabetes and Cardiovascular Disease: Implications for Prognosis and Treatment.
Strawbridge RJ; van Zuydam NR
Curr Diab Rep; 2018 Jun; 18(8):59. PubMed ID: 29938349
[TBL] [Abstract][Full Text] [Related]
40. Common Key Genes in Differentiating Parathyroid Adenoma From Thyroid Adenoma.
Lin Y; He J; Mou Z; Tian Y; Chen H; Guan T; Chen L
Horm Metab Res; 2023 Mar; 55(3):212-221. PubMed ID: 36599456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
